[Certolizumab]

Ann Dermatol Venereol. 2019 Jun-Jul;146(6-7):487-491. doi: 10.1016/j.annder.2019.04.004. Epub 2019 Jun 14.

[Article in French]

Authors

J Charles¹; Groupe de recherche sur le psoriasis de la Société française de dermatologie

Affiliation

¹ Service de dermato-vénéréologie, photobiologie et allergologie, CHU Grenoble-Alpes, CS 10 217, 38043 Grenoble cedex 9, France; Équipe immunobiology and immunotherapy in chronic diseases, CNRS UMR 5309, Inserm U 1209, université Grenoble-Alpes, Institute for Advanced Biosciences, 38700 La Tronche, France. Electronic address: [email protected].

PMID: 31208736
DOI: 10.1016/j.annder.2019.04.004

No abstract available

MeSH terms

Breast Feeding
Certolizumab Pegol / pharmacology*
Contraindications, Drug
Drug Monitoring
Female
Humans
Immunosuppressive Agents / pharmacology*
Pregnancy
Psoriasis / drug therapy

Substances

Immunosuppressive Agents
Certolizumab Pegol